Apollo Hospitals announces free Covid-19 vaccines to kids with co-morbidities
The list of kids with co-morbidities eligible for vaccination would be announced by the government
The list of kids with co-morbidities eligible for vaccination would be announced by the government
Continuum care is a concept that’s gaining acceptance in South India and Sukino Healthcare with its presence in Bangalore and Kochi has made rapid strides catering to this need. It now plans to expand to many more cities in the region. Indian Pharma Post caught up with Rajinish Menon, Founder & CEO, Sukino Healthcare who gave us an insight into the company’s operations.
The company operates four mid-sized hospitals with a total bed capacity of 556 in eastern India
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
The transaction is anticipated to close in the first quarter of 2022
The company plans to submit the IND application by the end of 2021
Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval
Droxidopa capsules, 100 mg, 200 mg, and 300 mg is a generic equivalent of Northera capsules, 100 mg, 200 mg, and 300 mg, of Lundbeck NA
It paves way for the launch of Selumetinib 10 mg & 25 mg capsule in India, subject to the receipt of related statutory approvals and licenses
Surufatinib is the third potential new medicine discovered by the company to enter into clinical development in Japan
Subscribe To Our Newsletter & Stay Updated